72 views

BONDOC ȘI ASOCIAȚII advised BFS Molecular, a software company focusing on next-generation sequencing-based patient testing solutions, in a transaction concerning the sale of its assets

BONDOC ȘI ASOCIAȚII advised BFS Molecular, a software company focusing on next-generation sequencing-based patient testing solutions, in a transaction concerning the sale of its assets, including intellectual property, to a leading precision medicine company acting in the field of solutions for transplant patients – CareDx Strengthens Bioinformatics Capabilities with Acquisition of BFS Molecular | CareDx (caredxinc.com)

The assistance was led by Monica Iancu, partner and included Daniela Gladunea and Horatiu Dumitru, managing associates. The team provided assistance on all Romanian law aspects of the transaction which involved complex legal issues around a portfolio of high value medical software and related intellectual property rights as well as the future of the cooperation between the acquiring entity and the founders of BFS Molecular.

The transaction confirms the expertise of BONDOC ȘI ASOCIAȚII in legal matters concerning highly innovative products including in the field of IT and medicine.

Related posts